8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Jan 7, 2008)

Filed January 7, 2008For Securities:BIIB

Summary

Biogen Idec Inc. (BIIB) filed an 8-K on January 7, 2008, primarily to furnish a press release dated the same day. This press release contained an update to the company's earnings guidance for the fiscal year ended December 31, 2007. Investors should note that this information was presented as a "furnishing" under Item 2.02 of the 8-K, meaning it is not considered "filed" for certain regulatory purposes and does not carry the same liabilities as a formally filed document. The key takeaway for investors is the need to refer to the content of the press release (Exhibit 99.1) for specific details on the updated financial estimates.

Key Highlights

  • 1Biogen Idec filed an 8-K on January 7, 2008.
  • 2The filing's main purpose was to announce an update to the company's earnings guidance for the year ended December 31, 2007.
  • 3The updated guidance was provided via a press release dated January 7, 2008.
  • 4The press release is included as Exhibit 99.1 to the 8-K.
  • 5The information furnished is not considered 'filed' under Section 18 of the Exchange Act, limiting liability.
  • 6Investors must consult the press release for the actual earnings guidance details.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report an update to Biogen Idec's earnings guidance for the fiscal year 2007, which was communicated through a press release issued on the same day.

The specific details of the updated earnings guidance are contained within the press release dated January 7, 2008, which is furnished as Exhibit 99.1 to this 8-K filing. Investors should refer to that document for the exact figures and commentary.

No, this 8-K filing does not contain new financial statements. It primarily serves to report an update to earnings guidance through a press release. Item 9.01 indicates only the press release as an exhibit.

When information is 'furnished' under Item 2.02, it means it is provided to the SEC for informational purposes but is not subject to the same regulatory scrutiny or liabilities as if it were 'filed' under other sections of the Exchange Act, such as Section 18.